Inter-changeable designation for Semglee in the US is a milestone achievement for Biocon Biologics Akanki Sharma Sep 6, 2021 Dr Arun Chandavarkar, Managing Director, Biocon Biologics talks to Akanki Sharma about his role and vision for the company, while…
Biocon Biologics promotes Shreehas Tambe to deputy chief executive officer EP News Bureau Mar 1, 2021 Biocon Biologics announced that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer of Biocon…
Biocon licenses three generic formulation products to China Medical System Holdings EP News Bureau Sep 13, 2019 Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products…
Biocon-Mylan programmes make clinical progress Sanjiv Das May 7, 2015 PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete Biocon has…